[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569721":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":23,"responsibleParty":42,"collaborators":44,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":48,"sex":54,"minAge":55,"maxAge":10,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":10,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Kerecis Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Thor closure patients",null,"Patients who achieved closure in during the THOR clinical trial",[13,19],{"name":14,"role":15,"phone":16,"phoneExt":17,"email":18},"Bennett Rogers","CONTACT","888-960-1343","1008","brogers@serenagroups.com",{"name":20,"role":15,"phone":21,"phoneExt":10,"email":22},"Thomas Serena, MD","814-688-4000","tserena@serenagroups.com",[24],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Serena Group","RECRUITING","Monroeville","Pennsylvania","15146","United States",{"type":32,"coordinates":33},"Point",[34,35],-79.7881,40.42118,{"lat":35,"lon":34},[38],{"name":39,"role":15,"phone":40,"phoneExt":10,"email":41},"Laura Serena","412-212-0123","lserena@serenagorups.com",{"type":43,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[45],{"name":25,"class":46},"OTHER","100569721",false,"NCT06697925","Evaluating the Durability of Closure for Venous Leg Ulcers","Prospective Multicenter Observational Study Evaluating the Durability of Closure for Venous Leg Ulcers Following a Randomized, Controlled, Clinical Trial","THORSDOTTIR","Inclusion Criteria:\n\n* 1\\. Subjects must have participated in the THOR trial and achieved complete closure by the 12-week endpoint.\n\nExclusion Criteria:\n\n* 1\\. Subjects who did not participate in the THOR trial. 2. Subjects who participated in the THOR trial and did not achieve complete closure.","ALL","18 Years",{"count":57,"type":58},150,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to determine the durability of closure for venous leg ulcer subjects that achieved closure in the THOR trial.",[62,63,64,65,66],"Venous Leg","Venous Leg Ulcer (VLU)","Venous Leg Ulcer","Venous Ulcer","VLU","2025-01-22",{"date":69,"type":70},"2025-01-24","ACTUAL",{"date":72,"type":58},"2025-01",{"date":74,"type":58},"2026-12",{"name":5,"class":6},1]